INITIAL ASSESSMENT OF REAL-WORLD USAGE OF EXTENDED-RELEASE INJECTABLE PALIPERIDONE PALMITATE AMONG MEDICAID INSURED SCHIZOPHRENIA PATIENTS

被引：0
|
作者：
Kamat, S. [1 ]
Gutierrez, B. [1 ]
Eramo, A. [2 ]
Zubek, D. [1 ]
Baker, R. A. [3 ]
Lin, J. [4 ]
Karson, C. [5 ]
机构：
[1] Otsuka Amer Pharmaceut Inc, Princeton, NJ USA
[2] H Lundbeck & Co AS, Copenhagen, Denmark
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[4] Novosys Hlth, Flemington, NJ USA
[5] CNK Consulting, Wayne, PA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1580
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [1] Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia
    Peters, Lindsey
    Dyer, Megan
    Schroeder, Emily
    D'Souza, Manoranjan S.
    JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (02) : 88 - 94
  • [2] Extended-Release Intramuscular Paliperidone Palmitate A Review of its Use in the Treatment of Schizophrenia
    Carter, Natalie J.
    DRUGS, 2012, 72 (08) : 1137 - 1160
  • [3] Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone
    Perry, Richard
    Wolberg, James
    DiCrescento, Steven
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (01) : 40 - 43
  • [4] Paliperidone extended-release in patients with schizophrenia and prominent affective symptoms
    Dirks, B.
    Canuso, C.
    Bossie, C.
    Turkoz, I.
    Verbanac, J.
    Mahmoud, R.
    Schreiner, A.
    BIPOLAR DISORDERS, 2007, 9 : 34 - 34
  • [5] Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia
    Canuso, C.
    Bossie, C.
    Amatniek, J.
    Turkoz, I.
    Pandina, G.
    Schreiner, A.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A99 - A99
  • [6] Paliperidone extended-release tablets in patients recently diagnosed with schizophrenia
    Kostic, D.
    Bossie, C.
    Turkoz, I.
    Bouhours, P.
    Canuso, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S161 - S161
  • [7] Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia
    Canuso, Carla M.
    Bossie, Cynthia A.
    Amatniek, Joan
    Turkoz, Ibrahim
    Pandina, Gahan
    Cornblatt, Barbara
    EARLY INTERVENTION IN PSYCHIATRY, 2010, 4 (01) : 64 - 78
  • [8] Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol
    Fadda, George
    Germain, Michael J.
    Broumand, Varshasb
    Nguyen, Andy
    McGarvey, November
    Gitlin, Matthew
    Bishop, Charles W.
    Ashfaq, Akhtar
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (10-11) : 798 - 807
  • [9] Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone
    Canuso, Carla M.
    Youssef, Eriene A.
    Bossie, Cynthia A.
    Turkoz, Ibrahim
    Schreiner, Andreas
    Simpson, George M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 209 - 215
  • [10] Effectiveness of paliperidone extended-release for patients with schizophrenia: focus on subjective improvement
    Na, Kyoung-Sae
    Kim, Chul-Eung
    Kim, Yong-Sik
    Lee, Jong-Il
    Han, Wou Sang
    Kang, Ung Gu
    Park, Doo-Heum
    Kim, Bongseog
    Jung, Han-Yong
    Yoon, Jin-Sang
    Lim, Se-Won
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (02) : 107 - 116
12345